An evolutionary view of drug-receptor interaction: the bioamine receptor family.
暂无分享,去创建一个
H Philippe | J. Vincent | H. Philippe | P. Vernier | B. Cardinaud | J D Vincent | B Cardinaud | O Valdenaire | O. Valdenaire | P Vernier
[1] P. Fishman,et al. Desensitization of the human beta 1-adrenergic receptor. Involvement of the cyclic AMP-dependent but not a receptor-specific protein kinase. , 1991, The Journal of biological chemistry.
[2] S. Liggett,et al. Human alpha 2-adrenergic receptor subtype distribution: widespread and subtype-selective expression of alpha 2C10, alpha 2C4, and alpha 2C2 mRNA in multiple tissues. , 1993, Molecular pharmacology.
[3] T. Ohta,et al. Synonymous and nonsynonymous substitutions in mammalian genes and the nearly neutral theory. , 1995, Journal of molecular evolution.
[4] B. Kobilka,et al. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors. , 1992, Molecular pharmacology.
[5] D. Hoyer,et al. Partial agonists, full agonists, antagonists: dilemmas of definition. , 1993, Trends in pharmacological sciences.
[6] S. Brenner,et al. Analysis of the dopamine receptor family in the compact genome of the puffer fish Fugu rubripes. , 1995, Genomics.
[7] R. Hen,et al. Of mice and flies: commonalities among 5-HT receptors. , 1992, Trends in pharmacological sciences.
[8] E. Fischer. Einfluss der Configuration auf die Wirkung der Enzyme , 1894 .
[9] Wen-Hsiung Li,et al. Fundamentals of molecular evolution , 1990 .
[10] D. Hoyer,et al. A proposed new nomenclature for 5-HT receptors. , 1993, Trends in pharmacological sciences.
[11] J. Baldwin. The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.
[12] J. Thorner,et al. Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.
[13] G Vriend,et al. A common step for signal transduction in G protein-coupled receptors. , 1994, Trends in pharmacological sciences.
[14] Jean Clobert,et al. Aspects of the genesis and maintenance of biological diversity , 1996 .
[15] E. Parker,et al. A Single Amino Acid Difference Accounts for the Pharmacological Distinctions Between the Rat and Human 5‐Hydroxytryptamine1B Receptors , 1993, Journal of neurochemistry.
[16] D Rodbard,et al. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. , 1992, Molecular pharmacology.
[17] B. O'dowd,et al. Heterogeneous tissue-specific transcription of dopamine receptor subtype messenger RNA in rat brain. , 1994, Brain research. Molecular brain research.
[18] H. Niznik,et al. The Dopamine D1D Receptor , 1995, The Journal of Biological Chemistry.
[19] R. Lefkowitz,et al. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.
[20] D. Mackay. Interpretation of relative potencies, relative efficacies and apparent affinity constants of agonist drugs estimated from concentration-response curves. , 1990, Journal of theoretical biology.
[21] P. Molinoff,et al. International Union of Pharmacology nomenclature of adrenoceptors. , 1994, Pharmacological reviews.
[22] J. Regan,et al. Selective coupling of alpha 2-adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells. , 1993, Molecular pharmacology.
[23] William R. Pearson,et al. Molecular characterization of α1- and α2-adrenoceptors , 1991 .
[24] G. Milligan,et al. Mechanisms of multifunctional signalling by G protein-linked receptors. , 1993, Trends in pharmacological sciences.
[25] M. Keen. Testing models of agonism for G protein-coupled receptors. , 1991, Trends in pharmacological sciences.
[26] P. Strange. New insights into dopamine receptors in the central nervous system , 1993, Neurochemistry International.
[27] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[28] Peter N. Devreotes,et al. G protein-linked signaling pathways control the developmental program of dictyostelium , 1994, Neuron.
[29] K. Kuma,et al. Functional constraints against variations on molecules from the tissue level: slowly evolving brain-specific genes demonstrated by protein kinase and immunoglobulin supergene families. , 1995, Molecular biology and evolution.
[30] S. Watson,et al. Receptor subtypes or species homologues: relevance to drug discovery. , 1993, Trends in pharmacological sciences.
[31] J. B. Walsh,et al. How often do duplicated genes evolve new functions? , 1995, Genetics.
[32] J. Felsenstein. Phylogenies from molecular sequences: inference and reliability. , 1988, Annual review of genetics.
[33] B. Kobilka,et al. A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists. , 1991, The Journal of biological chemistry.